Literature DB >> 17507515

First insight into the population structure of Mycobacterium tuberculosis in Saudi Arabia.

Sahal A M Al-Hajoj1, Thierry Zozio, Fahad Al-Rabiah, Viquar Mohammad, Maryam Al-Nasser, Christophe Sola, Nalin Rastogi.   

Abstract

This study constitutes a first attempt to describe the genetic population structure and drug resistance of the tubercle bacilli circulating in Saudi Arabia. A total of 1,505 clinical isolates of M. tuberculosis, isolated between 2002 and 2005 from seven regions of Saudi Arabia, were studied. The sample studied showed a male-to-female sex ratio of 1.27, with half of the cases among foreign-born individuals and 47% within the 21- to 40-year-old age group; a total resistance rate of 19.7%; and multiple drug resistance of 4.5%. Upon spoligotyping, a total of 387 individual patterns were obtained (clustering rate, 86.4%; 182 clusters containing between 2 and 130 isolates per cluster). A total of 94% of the strains matched the spoligotype patterns in an international database. Nearly 81% of the isolates in this study belonged to established phylogeographic clades: Central Asian (CAS), 22.5%; ill-defined T clade, 19.5%; East African-Indian (EAI), 13.5%; Haarlem, 7.5%; Latin American-Mediterranean, 7.2%; Beijing, 4.4%; Manu, 2.7%; X, 0.9%; and Bovis, 0.9%. Two clonal complexes with unique spoligotyping signatures (octal codes 703777707770371 and 467777377413771) specific to Saudi Arabia were identified. These belonged to the CAS and EAI clades, respectively, as confirmed upon secondary typing using mycobacterial interspersed repetitive units (MIRUs). The results obtained underline the predominance of historic clones of principal genetic group 1, which are responsible for roughly 45% of all tuberculosis cases in Saudi Arabia. The high rate of clustering observed might be an indication of rapid ongoing transmission within certain communities and/or subpopulations in Saudi Arabia; nonetheless, spoligotyping is known to overestimate clustering, and only a systematic second-line typing, such as MIRUs, coupled with a better tuberculosis registry and epidemiological investigations would allow us to know the exact rate of ongoing transmission and associated risk factors in Saudi Arabia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17507515      PMCID: PMC1951255          DOI: 10.1128/JCM.02293-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  Role of tuberculosis laboratories in Saudi Arabia. A call to implement standardized procedures.

Authors:  Sahal A Al-Hajoj; Fahad A Alrabiah
Journal:  Saudi Med J       Date:  2004-11       Impact factor: 1.484

2.  Genetic analysis of mycobacterium tuberculosis strains isolated in Ural region, Russian Federation, by MIRU-VNTR genotyping.

Authors:  S Y Kovalev; E Y Kamaev; M A Kravchenko; N E Kurepina; S N Skorniakov
Journal:  Int J Tuberc Lung Dis       Date:  2005-07       Impact factor: 2.373

3.  Spoligotyping of Mycobacterium tuberculosis isolates from patients with pulmonary tuberculosis in Mumbai, India.

Authors:  Savita Kulkarni; Christophe Sola; Ingrid Filliol; Nalin Rastogi; Gururaj Kadival
Journal:  Res Microbiol       Date:  2005-02-07       Impact factor: 3.992

4.  Automated high-throughput genotyping for study of global epidemiology of Mycobacterium tuberculosis based on mycobacterial interspersed repetitive units.

Authors:  P Supply; S Lesjean; E Savine; K Kremer; D van Soolingen; C Locht
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

5.  Comparison of methods based on different molecular epidemiological markers for typing of Mycobacterium tuberculosis complex strains: interlaboratory study of discriminatory power and reproducibility.

Authors:  K Kremer; D van Soolingen; R Frothingham; W H Haas; P W Hermans; C Martín; P Palittapongarnpim; B B Plikaytis; L W Riley; M A Yakrus; J M Musser; J D van Embden
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

6.  Mycobacterium tuberculosis phylogeny reconstruction based on combined numerical analysis with IS1081, IS6110, VNTR, and DR-based spoligotyping suggests the existence of two new phylogeographical clades.

Authors:  C Sola; I Filliol; E Legrand; I Mokrousov; N Rastogi
Journal:  J Mol Evol       Date:  2001-12       Impact factor: 2.395

7.  Global phylogeny of Mycobacterium tuberculosis based on single nucleotide polymorphism (SNP) analysis: insights into tuberculosis evolution, phylogenetic accuracy of other DNA fingerprinting systems, and recommendations for a minimal standard SNP set.

Authors:  Ingrid Filliol; Alifiya S Motiwala; Magali Cavatore; Weihong Qi; Manzour Hernando Hazbón; Miriam Bobadilla del Valle; Janet Fyfe; Lourdes García-García; Nalin Rastogi; Christophe Sola; Thierry Zozio; Marta Inírida Guerrero; Clara Inés León; Jonathan Crabtree; Sam Angiuoli; Kathleen D Eisenach; Riza Durmaz; Moses L Joloba; Adrian Rendón; José Sifuentes-Osornio; Alfredo Ponce de León; M Donald Cave; Robert Fleischmann; Thomas S Whittam; David Alland
Journal:  J Bacteriol       Date:  2006-01       Impact factor: 3.490

8.  Novel genetic polymorphisms that further delineate the phylogeny of the Mycobacterium tuberculosis complex.

Authors:  Richard C Huard; Michel Fabre; Petra de Haas; Luiz Claudio Oliveira Lazzarini; Dick van Soolingen; Debby Cousins; John L Ho
Journal:  J Bacteriol       Date:  2006-06       Impact factor: 3.490

Review 9.  Molecular epidemiology of tuberculosis and other mycobacterial infections: main methodologies and achievements.

Authors:  D Van Soolingen
Journal:  J Intern Med       Date:  2001-01       Impact factor: 8.989

10.  Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology.

Authors:  Karine Brudey; Jeffrey R Driscoll; Leen Rigouts; Wolfgang M Prodinger; Andrea Gori; Sahal A Al-Hajoj; Caroline Allix; Liselotte Aristimuño; Jyoti Arora; Viesturs Baumanis; Lothar Binder; Patricia Cafrune; Angel Cataldi; Soonfatt Cheong; Roland Diel; Christopher Ellermeier; Jason T Evans; Maryse Fauville-Dufaux; Séverine Ferdinand; Dario Garcia de Viedma; Carlo Garzelli; Lidia Gazzola; Harrison M Gomes; M Cristina Guttierez; Peter M Hawkey; Paul D van Helden; Gurujaj V Kadival; Barry N Kreiswirth; Kristin Kremer; Milan Kubin; Savita P Kulkarni; Benjamin Liens; Troels Lillebaek; Minh Ly Ho; Carlos Martin; Christian Martin; Igor Mokrousov; Olga Narvskaïa; Yun Fong Ngeow; Ludmilla Naumann; Stefan Niemann; Ida Parwati; Zeaur Rahim; Voahangy Rasolofo-Razanamparany; Tiana Rasolonavalona; M Lucia Rossetti; Sabine Rüsch-Gerdes; Anna Sajduda; Sofia Samper; Igor G Shemyakin; Urvashi B Singh; Akos Somoskovi; Robin A Skuce; Dick van Soolingen; Elisabeth M Streicher; Philip N Suffys; Enrico Tortoli; Tatjana Tracevska; Véronique Vincent; Tommie C Victor; Robin M Warren; Sook Fan Yap; Khadiza Zaman; Françoise Portaels; Nalin Rastogi; Christophe Sola
Journal:  BMC Microbiol       Date:  2006-03-06       Impact factor: 3.605

View more
  24 in total

1.  Spoligotype profile of Mycobacterium tuberculosis complex strains from HIV-positive and -negative patients in Nigeria: a comparative analysis.

Authors:  Simeon Cadmus; Véronique Hill; Dick van Soolingen; Nalin Rastogi
Journal:  J Clin Microbiol       Date:  2010-11-03       Impact factor: 5.948

2.  Epidemiology of antituberculosis drug resistance in Saudi Arabia: findings of the first national survey.

Authors:  Sahal Al-Hajoj; Bright Varghese; Mohammed M Shoukri; Ruba Al-Omari; Mais Al-Herbwai; Fahad Alrabiah; Abdulrahman A Alrajhi; Naila Abuljadayel; Sahar Al-Thawadi; Alimuddin Zumla; Matteo Zignol; Mario C Raviglione; Ziad Memish
Journal:  Antimicrob Agents Chemother       Date:  2013-03-04       Impact factor: 5.191

3.  Can we change the way we look at BCG vaccine?

Authors:  Sahal Abdulaziz Al-Hajoj
Journal:  Ann Thorac Med       Date:  2009-04       Impact factor: 2.219

4.  Polymorphic exact tandem repeat A (PETRA): a newly defined lineage of mycobacterium tuberculosis in israel originating predominantly in Sub-Saharan Africa.

Authors:  Paul J Freidlin; Drora Goldblatt; Hasia Kaidar-Shwartz; Efrat Rorman
Journal:  J Clin Microbiol       Date:  2009-10-21       Impact factor: 5.948

5.  Molecular characterization of Mycobacterium tuberculosis isolates from different regions of Bulgaria.

Authors:  Violeta Valcheva; Igor Mokrousov; Nalin Rastogi; Olga Narvskaya; Nadya Markova
Journal:  J Clin Microbiol       Date:  2008-01-16       Impact factor: 5.948

6.  Genotyping of Pulmonary Mycobacterium tuberculosis Isolates from Sudan Using Spoligotyping.

Authors:  Muataz M Eldirdery; Intisar E Alrayah; Mona Oa Awad ElkareIm; Fatima A Khalid; Asrar M A/Salam Elegail; Nuha Y Ibrahim; Eman O M Nour; Rahma H Ali; Elena Hailu; Markos Abebe; Abraham Aseffa; Najem Aldin M Osman; Maowia M Mukhtar; Nihad M A Elhaj; Atif A Elagib
Journal:  Am J Microbiol Res       Date:  2015

7.  Unexpectedly high proportion of ancestral Manu genotype Mycobacterium tuberculosis strains cultured from tuberculosis patients in Egypt.

Authors:  Zeinab H Helal; Mohamed Seif El-Din Ashour; Somaia A Eissa; Ghanem Abd-Elatef; Thierry Zozio; Sankhiros Babapoor; Nalin Rastogi; Mazhar I Khan
Journal:  J Clin Microbiol       Date:  2009-06-24       Impact factor: 5.948

8.  Molecular identification of Mycobacterium tuberculosis causing Pulmonary Tuberculosis in Sudan.

Authors:  Fatima Abbas Khalid; Nagla Gasmelseed; Elena Hailu; Muataz Mohamed Eldirdery; Markos Abebe; Stefan Berg; Abraham Aseffa
Journal:  Eur Acad Res       Date:  2016-12

9.  Significance of the identification in the Horn of Africa of an exceptionally deep branching Mycobacterium tuberculosis clade.

Authors:  Yann Blouin; Yolande Hauck; Charles Soler; Michel Fabre; Rithy Vong; Céline Dehan; Géraldine Cazajous; Pierre-Laurent Massoure; Philippe Kraemer; Akinbowale Jenkins; Eric Garnotel; Christine Pourcel; Gilles Vergnaud
Journal:  PLoS One       Date:  2012-12-27       Impact factor: 3.240

10.  Admixed phylogenetic distribution of drug resistant Mycobacterium tuberculosis in Saudi Arabia.

Authors:  Bright Varghese; Philip Supply; Caroline Allix-Béguec; Mohammed Shoukri; Ruba Al-Omari; Mais Herbawi; Sahal Al-Hajoj
Journal:  PLoS One       Date:  2013-02-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.